Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco January DIC 600x60px
Document › Details

Teva Pharmaceutical Industries Ltd.. (5/11/17). "Press Release: Teva Reports First Quarter 2017 Financial Results". Jerusalem.

Organisations Organisation Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA)
  Group Teva (Group)
  Organisation 2 Actavis (Group) (new, since Jan 2013)
  Today Allergan (Group)
  Group Teva (Group)
Products Product pharmaceutical
  Product 2 DRUGS, GENERICS
  Index term 2 Allergan–Teva: investment, 201608 acquisition of Actavis generics business from Allergan plc for $33.43b in cash + 100m Teva shares
Person Person Peterburg, Yitzhak (Teva 201702– Interim CEO)
     


   
Record changed: 2017-05-15

Advertisement

Picture [iito] – Putting Information into Context 600x60px

More documents for Teva (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco January DIC 600x60px




» top